CN1562966A - 一种新的制备布洛芬精氨酸盐的方法 - Google Patents
一种新的制备布洛芬精氨酸盐的方法 Download PDFInfo
- Publication number
- CN1562966A CN1562966A CN 200410014369 CN200410014369A CN1562966A CN 1562966 A CN1562966 A CN 1562966A CN 200410014369 CN200410014369 CN 200410014369 CN 200410014369 A CN200410014369 A CN 200410014369A CN 1562966 A CN1562966 A CN 1562966A
- Authority
- CN
- China
- Prior art keywords
- ibuprofen
- preparation
- arginine
- arginine salt
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title abstract description 9
- -1 brufen arginine salt Chemical class 0.000 title description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 31
- 239000004475 Arginine Substances 0.000 claims abstract description 19
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 19
- 238000006243 chemical reaction Methods 0.000 claims abstract description 12
- 239000002904 solvent Substances 0.000 claims abstract description 11
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims description 30
- 229960001680 ibuprofen Drugs 0.000 claims description 30
- GCCOJNYCFNSJII-VWMHFEHESA-N [n'-[(4s)-4-amino-4-carboxybutyl]carbamimidoyl]azanium;2-[4-(2-methylpropyl)phenyl]propanoate Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N.CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 GCCOJNYCFNSJII-VWMHFEHESA-N 0.000 claims description 25
- 238000002360 preparation method Methods 0.000 claims description 20
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 4
- 238000002425 crystallisation Methods 0.000 claims description 3
- 230000008025 crystallization Effects 0.000 claims description 3
- 150000002191 fatty alcohols Chemical class 0.000 claims description 3
- 230000001476 alcoholic effect Effects 0.000 claims description 2
- 239000000376 reactant Substances 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 239000013078 crystal Substances 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 2
- 150000001483 arginine derivatives Chemical class 0.000 abstract 2
- 230000000977 initiatory effect Effects 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 235000009697 arginine Nutrition 0.000 description 17
- 239000000047 product Substances 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 239000007810 chemical reaction solvent Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 230000003637 steroidlike Effects 0.000 description 2
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 1
- BMFMQGXDDJALKQ-BYPYZUCNSA-N Argininic acid Chemical class NC(N)=NCCC[C@H](O)C(O)=O BMFMQGXDDJALKQ-BYPYZUCNSA-N 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000012716 precipitator Substances 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410014369 CN1246306C (zh) | 2004-03-19 | 2004-03-19 | 一种制备布洛芬精氨酸盐的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410014369 CN1246306C (zh) | 2004-03-19 | 2004-03-19 | 一种制备布洛芬精氨酸盐的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1562966A true CN1562966A (zh) | 2005-01-12 |
CN1246306C CN1246306C (zh) | 2006-03-22 |
Family
ID=34478324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200410014369 Expired - Lifetime CN1246306C (zh) | 2004-03-19 | 2004-03-19 | 一种制备布洛芬精氨酸盐的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1246306C (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101570480A (zh) * | 2009-06-18 | 2009-11-04 | 航天中心医院 | 一种右旋布洛芬氨基酸盐的制备方法 |
CN101817765A (zh) * | 2010-04-16 | 2010-09-01 | 山东新华制药股份有限公司 | 布洛芬精氨酸盐的制备方法 |
CN102180786A (zh) * | 2011-03-30 | 2011-09-14 | 吴家安 | 右旋布洛芬精氨酸盐及其制备方法 |
CN102617330A (zh) * | 2012-03-15 | 2012-08-01 | 合肥科大生物技术有限公司 | 一种布洛芬精氨酸盐的制备方法 |
CN101455654B (zh) * | 2007-12-13 | 2013-03-06 | 天津医科大学 | 精氨酸布洛芬凝胶剂及其制备方法 |
CN103130637A (zh) * | 2013-03-19 | 2013-06-05 | 中国药科大学 | 一种布洛芬精氨酸盐及其制备方法 |
CN106110328A (zh) * | 2016-06-30 | 2016-11-16 | 山东理工大学 | 一种利用磷酸钙沉淀辅助提高布洛芬在水中溶解度的方法 |
CN107935890A (zh) * | 2017-12-28 | 2018-04-20 | 山东新华制药股份有限公司 | 布洛芬精氨酸注射液酰胺杂质的制备方法 |
-
2004
- 2004-03-19 CN CN 200410014369 patent/CN1246306C/zh not_active Expired - Lifetime
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101455654B (zh) * | 2007-12-13 | 2013-03-06 | 天津医科大学 | 精氨酸布洛芬凝胶剂及其制备方法 |
CN101570480A (zh) * | 2009-06-18 | 2009-11-04 | 航天中心医院 | 一种右旋布洛芬氨基酸盐的制备方法 |
CN101817765A (zh) * | 2010-04-16 | 2010-09-01 | 山东新华制药股份有限公司 | 布洛芬精氨酸盐的制备方法 |
CN102180786A (zh) * | 2011-03-30 | 2011-09-14 | 吴家安 | 右旋布洛芬精氨酸盐及其制备方法 |
CN102617330A (zh) * | 2012-03-15 | 2012-08-01 | 合肥科大生物技术有限公司 | 一种布洛芬精氨酸盐的制备方法 |
CN102617330B (zh) * | 2012-03-15 | 2014-11-19 | 合肥科大生物技术有限公司 | 一种布洛芬精氨酸盐的制备方法 |
CN103130637A (zh) * | 2013-03-19 | 2013-06-05 | 中国药科大学 | 一种布洛芬精氨酸盐及其制备方法 |
CN106110328A (zh) * | 2016-06-30 | 2016-11-16 | 山东理工大学 | 一种利用磷酸钙沉淀辅助提高布洛芬在水中溶解度的方法 |
CN107935890A (zh) * | 2017-12-28 | 2018-04-20 | 山东新华制药股份有限公司 | 布洛芬精氨酸注射液酰胺杂质的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1246306C (zh) | 2006-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1246306C (zh) | 一种制备布洛芬精氨酸盐的方法 | |
CN1336920A (zh) | 泰米沙丹的多晶型物,其制备方法及其在制备药物组合物中的用途 | |
US8524944B2 (en) | Process for the preparation of sodium gamma-hydroxybutyrate | |
CN1453284A (zh) | 一种三氯蔗糖的合成方法 | |
CN105348351B (zh) | 制备甲基四烯物的方法 | |
CN103204819B (zh) | 氘代***及其制备方法 | |
CN111100178B (zh) | 一种药用级胆固醇硫酸酯钠的制备方法 | |
US20080207945A1 (en) | Preparation of gabapentin by liquid-liquid extraction | |
CN107674074B (zh) | 一种两亲性萘酰双亚胺凝胶因子的制备方法及应用 | |
CN109422642B (zh) | 苯甲酸的精制方法、药用级苯甲酸钠的生产方法和设备 | |
CN1196351A (zh) | 三甲铵乙内酯(甜菜碱)的合成与分离方法 | |
CN102504160B (zh) | 利用合成阿司匹林废液制备混凝土高效减水剂方法 | |
CN102010345B (zh) | 一种动态动力学拆分制备d-苯丙氨酸的方法 | |
CN104418825B (zh) | 利普司他汀的提纯方法 | |
CN101028988A (zh) | β-甲基萘的纯化方法 | |
CN111320712B (zh) | 一种舒更葡糖钠分子内硫醚杂质的合成方法 | |
CN103204856B (zh) | 氘代阿普***及其制备方法 | |
CN102827229A (zh) | 一种纯化卤米松羧酸酯的方法 | |
CN105566141B (zh) | 一种门冬氨酸缩合物的制备方法 | |
JPH08143585A (ja) | O,s−ジメチル n−アセチルホスホルアミドチオエートの精製法 | |
CN115611908B (zh) | 一种普拉洛芬的制备方法 | |
CN112375031B (zh) | 一种西尼地平的制备方法 | |
CN114773255B (zh) | 一种绿原酸类似物及其制备方法与应用 | |
CN102993145B (zh) | 一种提取纯化洛伐他汀的方法 | |
CN102219793B (zh) | D(-)-磺苄西林钠的提纯方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: TAIYANGSHI (TANGSHAN) PHARMACEUTICAL CO. LTD.; CHI Free format text: FORMER NAME OR ADDRESS: CHINA PHARMACY UNIVERSITY |
|
CP03 | Change of name, title or address |
Address after: Hebei Tangshan City hi tech Development Zone zip code: 063020 Co-patentee after: CHINA PHARMACEUTICAL University Patentee after: SUNSTONE (TANGSHAN) PHARMACEUTICAL CO.,LTD. Address before: Tong Xiang Nanjing city of Jiangsu Province, No. 24 Patentee before: China Pharmaceutical University |
|
CP03 | Change of name, title or address |
Address after: 063020 Torch Road, Tangshan City hi tech Development Zone, Hebei 139, China Co-patentee after: CHINA PHARMACEUTICAL University Patentee after: China Resources Sanjiu (Tangshan) Pharmaceutical Co.,Ltd. Address before: 063020 Tangshan City hi tech Development Zone, Hebei Co-patentee before: CHINA PHARMACEUTICAL University Patentee before: SUNSTONE (TANGSHAN) PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CX01 | Expiry of patent term |
Granted publication date: 20060322 |
|
CX01 | Expiry of patent term |